期刊文献+

三维适形放疗联合替吉奥治疗老年食管癌患者的临床研究 被引量:11

Clinical study of S-1 combined with three-dimensional conformal radiotherapy for elderly patients with esophageal cancer
下载PDF
导出
摘要 目的:探讨替吉奥联合三维适形放疗治疗老年食管癌患者的临床疗效。方法:76例老年食管癌患者随机分为替吉奥联合放疗组(38例)和单独放疗组(38例)。两组均采用三维适形放疗,联合组在放疗同期行替吉奥单药化疗,60mg/(m2·d),同时给予一定的对症支持治疗。治疗前后行上消化道造影、胸部CT等检查,以评价疗效。结果:联合组总有效率为89.5%,单放组总有效率为68.4%,差异具有统计学意义(P<0.05)。两组主要毒副反应为食管炎、血液学毒性,患者均可耐受。结论:三维适形放疗联合替吉奥治疗老年食管癌患者,疗效较好,不良反应可以耐受,值得进一步推广应用。 Objective:To investigate the clinical effects of S - 1 combined with three - dimensional conformal ra- diotherapy (3DCRT) for elderly patients with esophageal cancer. Methods:A total of 76 elderly patients with esopha- geal cancer were randomly divided into chemoradiotherapy group (S1 combined with 3DCRT, n = 36) and radiothera- py alone group( n = 36). 3DCRT was adopted in the two groups. Patients in chemoradiotherapy group received S - 1 60mg/( m2 · d) concurrent with 3DCRT. Upper digestive tract radiograph, chest CT were performed before and after the treatment. Results:In chemoradiotherapy and radiotherapy alone groups, the total effective rates (CR + PR) were 89.5% and 68.4% ,respectively. There was significant difference between two gronps(P 〈 0.05 ). The main adverse effects were esophagitis and hematological toxicities. Conclusion:S - 1 combined with 3DCRT for elderly patients with esophageal cancer is effective and tolerable.
出处 《现代肿瘤医学》 CAS 2013年第12期2721-2722,共2页 Journal of Modern Oncology
关键词 替吉奥 三维适形放疗 食管癌 S - 1 three - dimensional conformal radiotherapy esophageal cancer
  • 相关文献

参考文献12

二级参考文献75

  • 1师颖瑞,吴湘玮,陈艳平,张九堂,范长根,韩亚骞.后程加速超分割适形放疗加同步化疗治疗食管癌的临床观察[J].中华肿瘤防治杂志,2008,15(12):943-945. 被引量:17
  • 2肖泽芬,章众,张红志,戴建荣,梁军,韩伟.用三维治疗计划系统评估食管癌常规放射治疗中肿瘤剂量的分布[J].中华放射肿瘤学杂志,2004,13(4):273-277. 被引量:173
  • 3李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:226
  • 4Perez CA, Miehalski JM. Threedimensional conformal therapy or standard irradiation in localized carcinoma of prostate: preliminary results of a nonrandomized comparison[J]. Int J Radiat Oncol Biol Phys, 2000,47(3) :629-637.
  • 5Kato H, Fukuchi M, Manda R, et al, Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas[J]. Anticancer Res, 2003, 23(4) :3493- 3498.
  • 6Wong SK, Chiu PW, Leung SF, et al. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study[J]. Ann Surg Oncol, 2008, 15(2) :576-582.
  • 7Yamada H,Uchida N, Maekawa R, et al. Sequence-dependent antitumor efficacy of combination chemotherapy with nedaplatin,a newly developed platinum, and paclitaxel[J]. Cancer Lett,2001,172(1) : 17-25.
  • 8Hartmann JT, Lipp HP. Toxicity of platinum Compounds [J]. Expert Opin pharmacother, 2003,4(6): 889-901.
  • 9Shirai T, Hirose T, Noda M. Phase Ⅱ study of the combination of gemcitabine and nedaplatin for advanced non-small-cell lung cancer[J]. Lung cancer, 2006,52(2) : 181-187.
  • 10Kanzawa F,Koizumi F,Koh Y,et al. In vitro synergisdc interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this in teraction[J]. Clinic Cancer Res,2001,7(1):202-209.

共引文献218

同被引文献95

  • 1杨峥,王旸,余杰,张森,刘瀚文.老年食管癌特征及放化疗结合与单纯放疗的疗效及安全性[J].中国老年学杂志,2014,34(3):778-779. 被引量:19
  • 2孙燕,石远凯.临床肿瘤内科手册[M].5版.北京:人民卫生出版社,2013:582-617.
  • 3Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J ]. CA Cancer J Clin,2011,61 (2) : 69 - 90.
  • 4Wang W, Li J, Zhang Y, et al. Comparison of patient - specific internal gross tumor volume for radiation treatment of primary esophageal cancer based separately on three -dimensional and four- dimensional computedtomography images [J ]. Dis Esophagus, 2014,27 (4) : 348 - 354.
  • 5Kole TP, Aghayere O, Kwah J, et al. Comparison of heart and coronary artery doses associated with intensity- modulated radiotherapy versus three - dimensional conformal radiotherapy for distal esophageal cancer[J]. Int J Radiat Oncol Biol Phys,2012,83 (5): 1 580 - 1 586.
  • 6Bedford JL, Viviers L, Guzel Z, et al. A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus [ J ]. Radiother Oncol, 2000,57 (2) : 183 - 193.
  • 7Furutani A, Sowa Y, Fujiwara H, et al. The Novel HDAC inhibitor OBP - 801/YM753 enhances the effects of 5- Fluorouracil with radiation on esophageal squamous carcinoma cells [J ]. Oncol Res, 2014,21 (5) : 281 - 286.
  • 8Fushimi K, Tanabe N, Takami M. A retrospective study of tegafur/uracil compared with cyclophosphamide, methotrexate, and fluorouracil as adju- vant chemotherapy in patients with node - negative, triple - negative breastcancer[J]. Gan To Kaqaku Ryoho,2014,41 (4) : 449 - 453.
  • 9Cho SH, Shim H J, Lee SR, et al. Concurrent chemoradiotherapy with S - 1 and cisplatin in advanced esophageal cancer [J]. Dis Esophagus, 2008, 21(8): 697 -703.
  • 10刘小群,乔田奎.三维适形放疗同步替吉奥治疗老年局部晚期食管癌效果观察[J].中国综合临床,2014,30(13):23-25.

引证文献11

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部